Betulinic acid regulates generation of neuroinflammatory mediators responsible for tissue destruction in multiple sclerosis in vitro

New and emerging disease modifying therapies for multiple sclerosis

(2012) Shiv Saidha et al.   Annals of the New York Academy of Sciences

Effect of betulinic acid on neutrophil recruitment and inflammatory mediator expression in lipopolysaccharide-induced lung inflammation in rats

(2012) Manar A. Nader et al.   EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES

CXCL12 in control of neuroinflammation

(2012) Miljana Momcilović et al.   IMMUNOLOGIC RESEARCH

Neuroinflammation: A Common Pathway in CNS Diseases as Mediated at the Blood-Brain Barrier

(2012) Michelle A. Erickson et al.   NEUROIMMUNOMODULATION

Oxidative damage in multiple sclerosis lesions

(2011) L. Haider et al.   BRAIN

Experimental autoimmune encephalomyelitis (EAE) as a model for multiple sclerosis (MS)

(2011) Cris S Constantinescu et al.   BRITISH JOURNAL OF PHARMACOLOGY

Nanostructures for Drug Delivery to the Brain

(2011) L. Martin-Banderas et al.   CURRENT MEDICINAL CHEMISTRY

Astrocytes in the tempest of multiple sclerosis

(2011) Djordje Miljković et al.   FEBS LETTERS

Chronic inflammation and immunologic-based constraints in malignant disease

(2011) Devin B Lowe et al.   Immunotherapy

Betulinic acid protects against cerebral ischemia–reperfusion injury in mice by reducing oxidative and nitrosative stress

(2011) Qing Lu et al.   NITRIC OXIDE-BIOLOGY AND CHEMISTRY

Correction: Defining Natural History: Assessment of the Ability of College Students to Aid in Characterizing Clinical Progression of Niemann-Pick Disease, Type C

(2011) Jenny Shin et al.   PLoS One

Triterpenoid modulation of IL-17 and Nrf-2 expression ameliorates neuroinflammation and promotes remyelination in autoimmune encephalomyelitis

(2011) Tej K. Pareek et al.   Scientific Reports

Radical changes in multiple sclerosis pathogenesis

(2010) Jack van Horssen et al.   BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE

Carbamate derivatives of betulinic acid and betulin with selective cytotoxic activity

(2010) Harish Kommera et al.   BIOORGANIC & MEDICINAL CHEMISTRY LETTERS

Small structural changes of pentacyclic lupane type triterpenoid derivatives lead to significant differences in their anticancer properties

(2010) Harish Kommera et al.   EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY

Current Views on the Roles of Th1 and Th17 Cells in Experimental Autoimmune Encephalomyelitis

(2010) Mohamed El-behi et al.   Journal of Neuroimmune Pharmacology

Lupane Triterpenoids—Betulin and Betulinic acid derivatives induce apoptosis in tumor cells

(2009) Harish Kommera et al.   INVESTIGATIONAL NEW DRUGS

Strain difference in susceptibility to experimental autoimmune encephalomyelitis in rats correlates with TH1 and TH17-inducing cytokine profiles

(2009) Milos Markovic et al.   MOLECULAR IMMUNOLOGY

Kinetics of IFN-γ and IL-17 expression and production in active experimental autoimmune encephalomyelitis in Dark Agouti rats

(2008) Miljana Momčilović et al.   NEUROSCIENCE LETTERS

Interleukin-17 Production in Central Nervous System-Infiltrating T Cells and Glial Cells Is Associated with Active Disease in Multiple Sclerosis

(2007) John S. Tzartos et al.   AMERICAN JOURNAL OF PATHOLOGY

Review: Oxidative stress and excitotoxicity: a therapeutic issue in multiple sclerosis?

(2007) R.E. Gonsette   Multiple Sclerosis Journal